ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

FGEN FibroGen Inc

1.02
0.00 (0.00%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 653,815
Bid Price 1.00
Ask Price 1.50
News -
Day High 1.06

Low
0.3333

52 Week Range

High
19.47

Day Low 0.9754
Share Name Share Symbol Market Stock Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.02 23:00:00
Open Price Low Price High Price Close Price Previous Close
1.04 0.9754 1.06 1.04 1.02
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
5,010 653,815 US$ 1.03 US$ 674,062 - 0.3333 - 19.47
Last Trade Type Quantity Price Currency
18:21:08 formt 500 US$ 1.02 USD

FibroGen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
102.72M 98.77M - 147.75M -284.23M -2.88 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

FibroGen News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No FGEN Message Board. Create One! See More Posts on FGEN Message Board See More Message Board Posts

Historical FGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.161.260.901051.061,378,356-0.14-12.07%
1 Month2.352.39750.901051.431,867,896-1.33-56.60%
3 Months2.3752.930.901051.942,191,651-1.36-57.05%
6 Months0.5182.930.33331.412,286,0570.50296.91%
1 Year16.3119.470.33332.532,894,380-15.29-93.75%
3 Years21.8130.12490.33337.651,619,097-20.79-95.32%
5 Years47.8057.20880.333315.271,297,232-46.78-97.87%

FibroGen Description

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Your Recent History

Delayed Upgrade Clock